Pharmacological |
Growth factors, slow-acting chondroprotective drugs, metformin |
Blood-derived products |
PRP, hyperacute serum, platelet lysate autologous conditioned serum, autologous protein solution |
Surgical |
Autologous osteochondral transplantation, autologous chondrocyte implantation, osteochondral allograft transplantation, costal cartilage grafts |
Cell-based therapy |
Chondrocytes, mesenchymal stem cells, exosomes, pluripotent stem cells |
Tissue engineering |
Endogenous cell homing, cell-based and cell-free scaffolds |
Gene therapy |
TissueGene-C based on TGF-β gene therapy |
Natural and synthetic biomaterials |
Hydrogels for cartilage regeneration |
Biomaterials used for drug delivery |
Chitosan nanodelivery platforms |